Three-year outcome analysis of alpha 1-blocker naftopidil for patients with benign prostatic hyperplasia in a prospective multicenter study in Japan.
Patient Prefer Adherence
; 10: 1309-16, 2016.
Article
in En
| MEDLINE
| ID: mdl-27524886
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Language:
En
Journal:
Patient Prefer Adherence
Year:
2016
Document type:
Article
Country of publication:
Nueva Zelanda